Jin Medical International Ltd's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Jin Medical International Ltd in the fourth quarter 2025?
Jin Medical International Ltd achieved a return on average equity (ROE) of 4.73 % in its fourth quarter 2025, which is below Jin Medical International Ltd's average return on equity, which stands at 8.26%.

ROE fell compared to the third quarter 2025, despite the net income growth of % from the third quarter 2025.

Within the Medical Equipment & Supplies industry 51 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from to 1863.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Sep 30 2023) IV. Quarter
Y / Y Equity Change	2.63 %	13.32 %	23.33 %	16.4 %	-
Y / Y Net Income Change	-52.01 %	-	-	-	-
Net Income (TTM) in Millions	1	3	3	3	3
Return On Equity (TTM)	4.73 %	9.93 %	10.24 %	10.77 %	11.19 %
ZJYL's Total Ranking	# 1863	#	#	#	#
Equity (TTM) in Millions	30	30	30	28	29
Seq. Equity Change	-0.22 %	0.22 %	5.95 %	-3.13 %	10.17 %
Seq. Net Income Change	-	-	-	-	-

Back to ZJYL Management Effectiveness >> ZJYL's 5 Years Annual ROE >> Compare ZJYL ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 52
Sector	# 166
Overall	# 1863

Return On Equity Statistics
High	Average	Low
11.87 %	8.26 %	4.66 %
(Sep 30 2024)		(Sep 30 2025)

ZJYL Annual Return On Equity	(Sep 30 2025) 2025	(Sep 30 2024) 2024	(Sep 30 2023) 2023
Total Equity in Millions	30	29	24	0	0
Y / Y Equity Change	2.86 %	20.17 %	-	-	-
Net Income in Millions	1	3	3	0	0
Y / Y Net Income Change	-59.61 %	18.82 %	-	-	-
Return On Equity	4.66 %	11.87 %	12 %	-	-

Back to ZJYL Management Effectiveness >> ZJYL's 5 Years Annual ROE >> Compare ZJYL ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 4.66 %, due to deterioration of net income.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ZJYL's' Return on Equity at Yahoo Finance
ZJYL's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ZJYL's Competitors
Subscribers only: Roe for Jin Medical International Ltd's Suppliers
Subscribers only: Return On Equity for ZJYL's Customers

Companies with similar Return On Equity at Sep 30 2025, within Healthcare Sector	ROE
Royalty Pharma Plc	12.68 %
U S Physical Therapy Inc	12.29 %
Boston Scientific Corporation	12.28 %
Pacific Health Care Organization Inc	11.79 %
Sotera Health Company	11.79 %
Hologic Inc	11.74 %
Progyny Inc	11.52 %
Protalix Biotherapeutics inc	11.28 %
Pfizer Inc	10.93 %
Teva Pharmaceutical Industries Limited	10.27 %
Steris Plc	10.25 %
Henry Schein Inc	10.24 %
Viemed Healthcare Inc	10.22 %
Labcorp Holdings Inc	10.22 %
National Healthcare Corp	10.15 %
Globus Medical Inc	9.99 %
Infusystem Holdings Inc	9.92 %
Utah Medical Products Inc	9.89 %
Medtronic Plc	9.80 %
Align Technology inc	9.75 %
Keros Therapeutics Inc	9.51 %
Vaso Corporation	9.49 %
Biogen Inc	9.25 %
Nature s Sunshine Products inc	9.24 %
Ani Pharmaceuticals Inc	9.20 %
The Pennant Group Inc	9.12 %
Select Medical Holdings Corp	9.00 %
Biomarin Pharmaceutical Inc	8.84 %
Tactile Systems Technology Inc	8.84 %
Addus Homecare Corp	8.49 %

Date modified: 2026-07-07T14:09:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.